Status:
WITHDRAWN
Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Urinary Bladder Cancer
Eligibility:
All Genders
65+ years
Brief Summary
This single arm pilot study will evaluate the feasibility and acceptability for perioperative Comprehensive Geriatric Assessment (CGA) and CGA-directed supportive and restorative care for patients wit...
Eligibility Criteria
Inclusion
- Ability of participant OR Legally Authorized Representative (LAR) to understand this study, and participant or LAR willingness to sign a written informed consent
- Males and females age ≥ 65 years
- Diagnosis/disease status
- Histologically proven muscle-invasive bladder cancer (MIBC) without metastatic disease.
- Patients planning to undergo neoadjuvant chemotherapy and radical cystectomy for MIBC.
- Treatment with investigational systemic therapy is permitted if participants will be receiving chemotherapy as part of their treatment plan
Exclusion
- Diagnosed with a psychiatric illness or is in a social situation that would limit compliance with study requirements
- Any other known invasive malignancy within previous 2 years with the following EXCEPT: low grade prostate cancer on active surveillance, chronic lymphocytic leukemia CLL on surveillance / observation, non-melanoma skin cancers
Key Trial Info
Start Date :
September 14 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 21 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05335707
Start Date
September 14 2022
End Date
August 21 2023
Last Update
February 28 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.